MOH — authorised 19 December 1985
- Marketing authorisation holder: ALLERGAN
- Status: likely_approved
MOH authorised Betagan on 19 December 1985
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 19 December 1985.
ALLERGAN holds the Israeli marketing authorisation.